Coronary Artery Disease (CAD)
The purpose of this study is to evaluate the effectiveness and safety of hybrid coronary revascularization (HCR) compared to multi-vessel percutaneous cardiac intervention (PCI) with metallic drug-eluting stents (DES) in patients with multi-vessel coronary artery disease (CAD) involving the left anterior descending (LAD) and/or left main (LM) arteries.
Principal Investigators: Robert L. Smith, II, MD / Molly Szerlip, MD
Locations: Baylor Scott & White The Heart Hospital – Plano
IRB Number: 017-097
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating may change your care
Rachelle Winkle, RN469.814.4183Rachelle.Winkle@BSWHealth.org
Heath Shirkey, RN469.814.4185Heath.Shirkey@BSWHealth.org
Randomized Trial of Hybrid Coronary Revascularization versus Percutaneous Coronary Intervention
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.